CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- 4 Open-market buy Chief Compliance Officer bought 5,000 shares at an average $20.08 ($100,400)
- 4 Open-market buy Chief Operating Officer bought 5,000 shares at $20.50 ($102,500)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Gift Chief Executive Officer gave 20,000 shares (gift)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Technology Officer acquired 1,000,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 1,000,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Acquisition Officer acquired 105,288 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 800,000 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 401,000 shares at $1.00 ($401,000)
- 4 Open-market buy Director bought 45,000 shares at an average $1.29 ($58,093)
- 4 Open-market buy Director bought 65,000 shares at an average $1.42 ($92,009)
- 4 Open-market buy Director bought 1,300 shares at an average $0.81 ($1,047)
Page 9 of 12 · 230 filings